Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hydrogel with Xenograft for Socket Preservation
NCT06957197Phase 3Not yet recruiting
- Sponsor
- Cairo University
- Start
- Sep 2025
- Primary completion
- Jul 2026
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial (2 arms), sponsored by Cairo University. Primary endpoint: Quantity of bone (bone height) at 3 months. Planned start Sep 2025; status: not yet recruiting.
Beyond the preview
Go deeper on NCT06957197.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06957197.